Transfection of HCVc improves hTERT expression through STAT3 pathway by epigenetic regulation in Huh7 cells

Journal of Cellular Biochemistry

Volumn 113, Issue 11, 2012, Pages 3419-3426

  Guo, Ning ^a   Cheng, Di ^b   Li, Zhi Hua ^b   Zhou, Quan Bo ^b   Zhou, Jia Jia ^b   Lin, Qing ^b   Zeng, Bing ^b   Liao, Qiaofang ^b   Chen, Ru Fu ^b  

^a SHANDONG UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

DNA METHYLTRANSFERASE; HCV; HEPATIC CARCINOMA; STAT3; TELOMERASE

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CORE PROTEIN; DNA METHYLTRANSFERASE 1; JANUS KINASE; STAT3 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; GENE OVEREXPRESSION; GENETIC REGULATION; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL PROLIFERATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENZYME INHIBITORS; EPIGENESIS, GENETIC; GENE EXPRESSION; HEPATOCYTES; HUMANS; JANUS KINASES; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TELOMERASE; TRANSFECTION; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 84866502538     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24218     Document Type: Article

References (23)

1. Chen RF, Li ZH, Liu RY, Kong XH, Tang QB, Wang J,. 2007. Malignant transformation of the cultured human normal biliary tract epithelial cells induced by hepatitis C virus core protein[J]. Oncol Rep 17 (1): 105-110.
2. Choi JH, Park SH, Park J, Park BG, Cha SJ, Kong KH, Lee KH, Park AJ,. 2007. Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma. Biochem Biophys Res Commun 361: 615-620.
3. Choi JH, Min NY, Park J, Kim JH, Park SH, Ko YJ, Kang Y, Moon YJ, Rhee S, Ham SW, Park AJ, Lee KH,. 2010. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116. Biochem Biophys Res Commun 391 (1): 449-454.
4. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA,. 2006. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8 (4): 416-424.
5. Guilleret I, Benhattar J,. 2004. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines. Biochem Biophys Res Commun 325: 1037-1043.
6. Guilleret I, Yan P, Grange F, Braunschweig R, Bosman FT, Benhattar J,. 2002. Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int J Cancer 101: 335-341.
7. Heathcote EJ,. 2004. Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology 127: S294-S302.
8. Hytiroglou P, Theise ND,. 2006. Telomerase activation in human hepatocarcinogenesis. Am J Gastroenterol 101 (4): 839-841.
9. Kasprzak A, Adamek A,. 2008. Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis. Hepatol Res 38 (1): 1-26.
10. Liu SX, Sun WS, Cao YL, Ma CH, Han LH, Zhang LN, Wang ZG, Zhu FL,. 2004. Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells. World J Gastroenterol 10: 366-370.
11. Meeran SM, Patel SN, Tollefsbol TO,. 2010. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS ONE 5 (7): e11457.
12. Ripoli M, Barbano R, Balsamo T, Piccoli C, Brunetti V, Coco M, Mazzoccoli G, Vinciguerra M, Pazienza V,. 2011. Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein. Virus Res 160 (1-2): 74-81.
13. Satyanarayana A, Manns MP, Rudolph KL,. 2004. Telomeres and telomerase: A dual role in hepatocarcinogenesis. Hepatology 40 (2): 276-283.
14. Schneider R, Bannister AJ, Kouzarides T,. 2002. Unsafe SETs: Histone lysine methyltransferases and cancer. Trends Biochem Sci 27: 396-402.
15. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G, Ide T,. 1995. Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55: 2734-2736.
16. Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T,. 2004. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 95 (7): 592-595.
17. Yang B, House MG, Guo M, Herman JG, Clark DP,. 2005. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangio-carcinoma. Mod Pathol 18: 412-420.
18. Zhang R, Wang X, Guo L, Xie H,. 2002a. Growth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptase. Int J Cancer 97: 173-179.
19. Zhang Q, Raghunath PN, Xue L, Majewski M, Carpentieri DF, Odum N, Morris S, Skorski T, Wasik MA,. 2002b. Multilevel dysregulation of STAT3 activation in ALK+ T/null cell lymphoma. J Immunol 68: 466-474.
20. Zhang Q, Wang HY, Marzec M, Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA,. 2005a. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci 102 (19): 6948-6953.
21. Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA,. 2005b. STAT3,DNMT1 mediated epigenetic silencing of SHP-1 tyrosinephosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci USA 102 (19): 6948-6953.
22. Zhaowen Z, Anne TW, Kota G, Zhu Z, Wilson AT, Gopalakrishna K, Brown KE, Luxon BA, Schmidt WN,. 2010. Hepatitis C virus core protein enhances telomerase activity in huh7 cells. J Med Virol 82 (2): 239-248.
23. Zinn RL, Pruitt K, Eguchi S, Baylin SB, Herman JG,. 2007. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 67 (1): 194-201.